ANX-514 (docetaxel injectable emulsion)

docetaxel · Mast Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ANX-514 (docetaxel injectable emulsion), covering 2009-05-28 to 2009-05-28. Get the full timeline:

Most recent: Clinical Trial Update: A Bioequivalence Study of Docetaxel for Injectable Emulsion (ANX-514) in Patients With Advanced Cancer [Phase 1]